A pharmacist framework for implementation of the Canadian Guideline for Opioids for Chronic Non-Cancer Pain

Murphy, Laura; Chang, Feng Yee; Dattani, Shelita; Sproule, Beth

doi:10.1177/1715163518818200

Cited by 5 publications

(5 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nevertheless, more research is needed to explore a practical pharmacist framework for pain management. Murphy, Chang, Dattani, and Sproule () proposed a pharmacist framework for implementation of the Canadian guideline for opioids for chronic non‐cancer pain. Given that our findings highlight the importance of pharmacists as members in opioid treatment, we can be inspired to establish a pharmacist framework for management of cancer pain, calling for pharmacists to actively take responsibility for relieving cancer pain.…”

Section: Discussionmentioning

confidence: 99%

Multidisciplinary intervention incorporating pharmacists in management of opioid‐naïve patients with moderate to severe cancer pain

et al. 2020

View full text Add to dashboard Cite

Objective This study aims to investigate the impact of intervention of multidisciplinary team incorporating pharmacists for management of opioid‐naïve patients with moderate to severe cancer pain. Methods A retrospective cohort study was conducted to compare pre‐ and post‐multidisciplinary intervention groups in opioid‐naïve patients with moderate to severe cancer pain. Primary outcome was the proportions of appropriate pain assessment and opioid titration. Secondary outcomes were pain intensity (PI), length of hospital stay, opioid escalation index percentage (OEI%) and incidences of opioid‐related adverse events. Results A total of 400 patients were included in the study (pre‐intervention, n = 200; post‐intervention, n = 200). Continuous improvement in pain assessment and titration was recorded after intervention. Though no substantial differences existed between groups in PI on the day of discharge, post‐intervention group was associated with reduced length of hospital stay as well as decreased proportion of subjects with OEI% >5%. As for safety, significant decreases in constipation and vomiting were seen. Conclusion Findings suggest that interventions of multidisciplinary team incorporating pharmacists could improve cancer pain management for opioid‐naïve patients. Pharmacists should be considered as an important member of a multidisciplinary team in good pain management.

show abstract

Section: Discussionmentioning

confidence: 99%

Multidisciplinary intervention incorporating pharmacists in management of opioid‐naïve patients with moderate to severe cancer pain

et al. 2020

View full text Add to dashboard Cite

show abstract

“…3 In 2019, an article was published that proposes a framework to help pharmacists implement opioid guideline recommendations into practice. 4 Unfortunately, studies evaluating the impact of pharmacist interventions, targeting opioid use in chronic noncancer pain, are limited. One retrospective chart audit evaluated 148 patients taking opioids for chronic noncancer pain in a Veterans Health clinic in California.…”

Section: Introductionmentioning

confidence: 99%

Impact of pharmacist-led medication assessments on opioid utilization

2020

View full text Add to dashboard Cite

“…Further work will be required to engage key stakeholders from primary care providers, policy makers, educational bodies to members of general practice multidisciplinary teams in order to ensure alignment and maintenance of standards within general practice. Additionally, we need to establish optimal implementation processes for these and other standards by assessing and providing the environmental and professional conditions necessary for evidencing the standards and linkage to nationally approved competency frameworks for advanced pharmacist practice [ 29 , 32 ]. Furthermore, research is required to explore how to standardise the time resource needed for these reviews, as no consensus was reached on this.…”

Section: Discussionmentioning

confidence: 99%

The standards of practice for delivery of polypharmacy and chronic disease medication reviews by general practice clinical pharmacists: a consensus study

et al. 2022

View full text Add to dashboard Cite

Background General practice in the UK is experiencing a crisis. Greater multidisciplinary working is a potential solution. The new general practice contract in Scotland encourages this and includes a new pharmacotherapy service to be delivered by General Practice Clinical Pharmacists (GPCPs). Consensus is lacking for the standards of practice for delivery of pharmacotherapy medication reviews (which are polypharmacy and chronic medication reviews) as part of this service. Aim To identify and validate standards of practice for polypharmacy and chronic disease medication (pharmacotherapy level 3) reviews conducted by GPCPs. Method A two-phased mixed-methods consensus methodology was used. Phase 1: An expert group of GPCPs (n = 4) and clinical pharmacist managers (n = 2) responsible for delivering the pharmacotherapy service used a Modified Nominal Group Technique to generate potential standards. Phase 2: Two-round Delphi survey involving GPCPs with ≥ 1 year of experience of working in general practice (n = 159). Results The expert group identified 44 potential standards of practice for polypharmacy and chronic disease reviews. Practicing GPCPs indicated during the Delphi phase that the 44 standards were applicable to practice. The standards of practice covered seven main categories: skills, environment, qualifications, qualities and behaviours, knowledge, process and experience. Conclusion Practicing GPCPs indicated that the standards identified by the expert group are acceptable and valid for current practice and the delivery of polypharmacy and chronic medication reviews. The application of these standards to practice may help GPCPs and general practices to ensure equitable delivery of patient care.

show abstract

A pharmacist framework for implementation of the Canadian Guideline for Opioids for Chronic Non-Cancer Pain

Cited by 5 publications

References 9 publications

Multidisciplinary intervention incorporating pharmacists in management of opioid‐naïve patients with moderate to severe cancer pain

Multidisciplinary intervention incorporating pharmacists in management of opioid‐naïve patients with moderate to severe cancer pain

Impact of pharmacist-led medication assessments on opioid utilization

The standards of practice for delivery of polypharmacy and chronic disease medication reviews by general practice clinical pharmacists: a consensus study

Contact Info

Product

Resources

About